Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
With the Fed set to act this month, a dirt-cheap stock looks attractive amid crosscurrents in the market. Here’s why ...
Two international small-cap funds, AVDV and DLS, offer different paths to income in a changing 2026 market. This divi...
When a global sports star jokes about starting a Spice Girls-style group after a baby reveal, it highlights more than...
Alphabet stock appears positioned to outpace the broader market in 2026 as AI leadership strengthens its cloud and se...
A new senior tax deduction linked to a Trump policy could cost Social Security $169 billion through 2028, prompting r...
Bitcoin weakness tracks chip-stock pressure as Nvidia falls and the ETH Foundation trims staff. Traders brace for rat...
Cynthia Lummis gave clarity on timing for the CLARITY Act, but the Senate path remains uncertain as lawmakers juggle ...
For 155 years, one benchmark on Wall Street has loomed as nearly invincible. Now signs are emerging that this longsta...
The market is navigating a phase many haven’t seen in a generation. Mega-cap tech dominates, valuations look stretche...
U.S. equities drift modestly lower as traders await Federal Reserve cues and key data. This stock market live july br...
XRP rose about 5% in the last 24 hours as holders show extreme on-chain metrics, sparking debate over whether a botto...